Shortening and Improving the Embryonic Stem Cell Test through the Use of Gene Biomarkers of Differentiation

The embryonic Stem cell Test (EST) is a validated assay for testing embryotoxicity in vitro. The total duration of this protocol is 10 days, and its main end-point is based on histological determinations. It is suggested that improvements on EST must be focused toward molecular end-points and, if po...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea C. Romero, Eugenio Vilanova, Miguel A. Sogorb
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Journal of Toxicology
Online Access:http://dx.doi.org/10.1155/2011/286034
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850173509598183424
author Andrea C. Romero
Eugenio Vilanova
Miguel A. Sogorb
author_facet Andrea C. Romero
Eugenio Vilanova
Miguel A. Sogorb
author_sort Andrea C. Romero
collection DOAJ
description The embryonic Stem cell Test (EST) is a validated assay for testing embryotoxicity in vitro. The total duration of this protocol is 10 days, and its main end-point is based on histological determinations. It is suggested that improvements on EST must be focused toward molecular end-points and, if possible, to reduce the total assay duration. Five days of exposure of D3 cells in monolayers under spontaneous differentiation to 50 ng/mL of the strong embryotoxic 5-fluorouracil or to 75 μg/mL of the weak embryotoxic 5,5-diphenylhydeantoin caused between 20 and 74% of reductions in the expression of the following genes: Pnpla6, Afp, Hdac7, Vegfa, and Nes. The exposure to 1 mg/mL of nonembryotoxic saccharin only caused statistically significant reductions in the expression of Nes. These exposures reduced cell viability of D3 cells by 15, 28, and 34%. We applied these records to the mathematical discriminating function of the EST method to find that this approach is able to correctly predict the embryotoxicity of all three above-mentioned chemicals. Therefore, this work proposes the possibility of improve EST by reducing its total duration and by introducing gene expression as biomarker of differentiation, which might be very interesting for in vitro risk assessment embryotoxicity.
format Article
id doaj-art-d2f021065d1246938b3da2137fede014
institution OA Journals
issn 1687-8191
1687-8205
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Journal of Toxicology
spelling doaj-art-d2f021065d1246938b3da2137fede0142025-08-20T02:19:50ZengWileyJournal of Toxicology1687-81911687-82052011-01-01201110.1155/2011/286034286034Shortening and Improving the Embryonic Stem Cell Test through the Use of Gene Biomarkers of DifferentiationAndrea C. Romero0Eugenio Vilanova1Miguel A. Sogorb2Unidad de Toxicología y Seguridad Química, Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, Avenida de la Universidad s/n, 03202 Elche, SpainUnidad de Toxicología y Seguridad Química, Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, Avenida de la Universidad s/n, 03202 Elche, SpainUnidad de Toxicología y Seguridad Química, Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, Avenida de la Universidad s/n, 03202 Elche, SpainThe embryonic Stem cell Test (EST) is a validated assay for testing embryotoxicity in vitro. The total duration of this protocol is 10 days, and its main end-point is based on histological determinations. It is suggested that improvements on EST must be focused toward molecular end-points and, if possible, to reduce the total assay duration. Five days of exposure of D3 cells in monolayers under spontaneous differentiation to 50 ng/mL of the strong embryotoxic 5-fluorouracil or to 75 μg/mL of the weak embryotoxic 5,5-diphenylhydeantoin caused between 20 and 74% of reductions in the expression of the following genes: Pnpla6, Afp, Hdac7, Vegfa, and Nes. The exposure to 1 mg/mL of nonembryotoxic saccharin only caused statistically significant reductions in the expression of Nes. These exposures reduced cell viability of D3 cells by 15, 28, and 34%. We applied these records to the mathematical discriminating function of the EST method to find that this approach is able to correctly predict the embryotoxicity of all three above-mentioned chemicals. Therefore, this work proposes the possibility of improve EST by reducing its total duration and by introducing gene expression as biomarker of differentiation, which might be very interesting for in vitro risk assessment embryotoxicity.http://dx.doi.org/10.1155/2011/286034
spellingShingle Andrea C. Romero
Eugenio Vilanova
Miguel A. Sogorb
Shortening and Improving the Embryonic Stem Cell Test through the Use of Gene Biomarkers of Differentiation
Journal of Toxicology
title Shortening and Improving the Embryonic Stem Cell Test through the Use of Gene Biomarkers of Differentiation
title_full Shortening and Improving the Embryonic Stem Cell Test through the Use of Gene Biomarkers of Differentiation
title_fullStr Shortening and Improving the Embryonic Stem Cell Test through the Use of Gene Biomarkers of Differentiation
title_full_unstemmed Shortening and Improving the Embryonic Stem Cell Test through the Use of Gene Biomarkers of Differentiation
title_short Shortening and Improving the Embryonic Stem Cell Test through the Use of Gene Biomarkers of Differentiation
title_sort shortening and improving the embryonic stem cell test through the use of gene biomarkers of differentiation
url http://dx.doi.org/10.1155/2011/286034
work_keys_str_mv AT andreacromero shorteningandimprovingtheembryonicstemcelltestthroughtheuseofgenebiomarkersofdifferentiation
AT eugeniovilanova shorteningandimprovingtheembryonicstemcelltestthroughtheuseofgenebiomarkersofdifferentiation
AT miguelasogorb shorteningandimprovingtheembryonicstemcelltestthroughtheuseofgenebiomarkersofdifferentiation